{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T02:16:32Z","timestamp":1789697792120,"version":"4.0.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2013,9,20]],"date-time":"2013-09-20T00:00:00Z","timestamp":1379635200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1007\/s10147-013-0616-8","type":"journal-article","created":{"date-parts":[[2013,9,19]],"date-time":"2013-09-19T09:04:54Z","timestamp":1379581494000},"page":"955-961","source":"Crossref","is-referenced-by-count":52,"title":["Current chemotherapeutic approaches for hepatoblastoma"],"prefix":"10.1007","volume":"18","author":[{"given":"Kenichiro","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,9,20]]},"reference":[{"issue":"16","key":"616_CR1","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1200\/JCO.2002.07.400","volume":"20","author":"HM Katzenstein","year":"2002","unstructured":"Katzenstein HM, London WB et al (2002) Treatment of unresectable and metastatic hepatoblastoma: a pediatric oncology group phase II study. J Clin Oncol 20(16):3438\u20133444","journal-title":"J Clin Oncol"},{"issue":"3","key":"616_CR2","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0022-3468(75)90095-0","volume":"10","author":"PR Exelby","year":"1975","unstructured":"Exelby PR, Filler RM, Grosfeld JL (1975) Liver tumors in children in the particular reference to hepatoblastoma and hepatocellular carcinoma: American academy of pediatrics surgical section survey\u20131974. J Pediatr Surg 10(3):329\u2013337","journal-title":"J Pediatr Surg"},{"issue":"11","key":"616_CR3","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/S0959-8049(00)00074-5","volume":"36","author":"J Brown","year":"2000","unstructured":"Brown J, Perilongo G, Shafford E et al (2000) Pretreatment prognostic factors for children with hepatoblastoma\u2014results from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1. Eur J Cancer 36(11):1418\u20131425","journal-title":"Eur J Cancer"},{"issue":"4","key":"616_CR4","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/1097-0142(197504)35:4<1083::AID-CNCR2820350410>3.0.CO;2-K","volume":"35","author":"CP Holton","year":"1975","unstructured":"Holton CP, Burrington JD, Hatch EI (1975) A multiple chemotherapeutic approach to the management of hepatoblastoma. A preliminary report. Cancer 35(4):1083\u20131087","journal-title":"Cancer"},{"issue":"1","key":"616_CR5","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1200\/JCO.1993.11.1.96","volume":"11","author":"EC Douglass","year":"1993","unstructured":"Douglass EC, Reynolds M, Finegold M et al (1993) Cisplatin, vincristine, and fluorouracil therapy for hepatoblastoma: a Pediatric Oncology Group study. J Clin Oncol: Off J Am Soc Clin Oncol 11(1):96\u201399","journal-title":"J Clin Oncol: Off J Am Soc Clin Oncol"},{"issue":"14","key":"616_CR6","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1200\/JCO.2000.18.14.2665","volume":"18","author":"JA Ortega","year":"2000","unstructured":"Ortega JA, Douglass EC, Feusner JH et al (2000) Randomized comparison of cisplatin\/vincristine\/fluorouracil and cisplatin\/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: a report from the Children\u2019s Cancer Group and the Pediatric Oncology Group. J Clin Oncol 18(14):2665\u20132675","journal-title":"J Clin Oncol"},{"issue":"18","key":"616_CR7","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1200\/JCO.2005.02.6013","volume":"24","author":"MH Malogolowkin","year":"2006","unstructured":"Malogolowkin MH, Katzenstein H, Krailo MD et al (2006) Intensified platinum therapy is an ineffective strategy for improving outcome in pediatric patients with advanced hepatoblastoma. J Clin Oncol 24(18):2879\u20132884. doi: 10.1200\/JCO.2005.02.6013","journal-title":"J Clin Oncol"},{"issue":"14","key":"616_CR8","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1200\/JCO.2006.09.7204","volume":"26","author":"MH Malogolowkin","year":"2008","unstructured":"Malogolowkin MH, Katzenstein HM, Krailo M et al (2008) Redefining the role of doxorubicin for the treatment of children with hepatoblastoma. J Clin Oncol 26(14):2379\u20132383. doi: 10.1200\/JCO.2006.09.7204","journal-title":"J Clin Oncol"},{"issue":"24","key":"616_CR9","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1200\/JCO.2010.29.3837","volume":"29","author":"MH Malogolowkin","year":"2011","unstructured":"Malogolowkin MH, Katzenstein HM, Meyers RL et al (2011) Complete surgical resection is curative for children with hepatoblastoma with pure fetal histology: a report from the Children\u2019s Oncology Group. J Clin Oncol 29(24):3301\u20133306. doi: 10.1200\/JCO.2010.29.3837","journal-title":"J Clin Oncol"},{"key":"616_CR10","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.2741\/e492","volume":"4","author":"MH Malogolowkin","year":"2012","unstructured":"Malogolowkin MH, Katzenstein HM, Krailo M et al (2012) Treatment of hepatoblastoma: the North American Cooperative Group experience. Front Biosci 4:1717\u20131723","journal-title":"Front Biosci"},{"issue":"5","key":"616_CR11","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/pbc.24219","volume":"59","author":"AD Trobaugh-Lotrario","year":"2012","unstructured":"Trobaugh-Lotrario AD, Katzenstein HM (2012) Chemotherapeutic approaches for newly diagnosed hepatoblastoma: past, present, and future strategies. Pediatr Blood Cancer 59(5):809\u2013812. doi: 10.1002\/pbc.24219","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"616_CR12","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/mpo.10300","volume":"41","author":"RD Palmer","year":"2003","unstructured":"Palmer RD, Williams DM (2003) Dramatic response of multiply relapsed hepatoblastoma to irinotecan (CPT-11). Med Pediatr Oncol 41(1):78\u201380. doi: 10.1002\/mpo.10300","journal-title":"Med Pediatr Oncol"},{"issue":"29","key":"616_CR13","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.1200\/JCO.2007.11.6103","volume":"25","author":"LR Bomgaars","year":"2007","unstructured":"Bomgaars LR, Bernstein M, Krailo M et al (2007) Phase II trial of irinotecan in children with refractory solid tumors: a Children\u2019s Oncology Group Study. J Clin Oncol 25(29):4622\u20134627. doi: 10.1200\/JCO.2007.11.6103","journal-title":"J Clin Oncol"},{"key":"616_CR14","doi-asserted-by":"crossref","first-page":"470","DOI":"10.2741\/e392","volume":"4","author":"P Czauderna","year":"2012","unstructured":"Czauderna P (2012) Hepatoblastoma throughout SIOPEL trials\u2014clinical lessons learnt. Front Biosci 4:470\u2013479","journal-title":"Front Biosci"},{"issue":"6","key":"616_CR15","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1200\/JCO.2005.07.145","volume":"23","author":"DC Aronson","year":"2005","unstructured":"Aronson DC, Schnater JM, Staalman CR et al (2005) Predictive value of the pretreatment extent of disease system in hepatoblastoma: results from the International Society of Pediatric Oncology Liver Tumor Study Group SIOPEL-1 study. J Clin Oncol 23(6):1245\u20131252. doi: 10.1200\/JCO.2005.07.145","journal-title":"J Clin Oncol"},{"issue":"3","key":"616_CR16","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ejca.2003.06.003","volume":"40","author":"G Perilongo","year":"2004","unstructured":"Perilongo G, Shafford E, Maibach R et al (2004) Risk-adapted treatment for childhood hepatoblastoma. final report of the second study of the International Society of Paediatric Oncology\u2013SIOPEL 2. Eur J Cancer 40(3):411\u2013421","journal-title":"Eur J Cancer"},{"issue":"17","key":"616_CR17","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1056\/NEJMoa0810613","volume":"361","author":"G Perilongo","year":"2009","unstructured":"Perilongo G, Maibach R, Shafford E et al (2009) Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma. N Engl J Med 361(17):1662\u20131670. doi: 10.1056\/NEJMoa0810613","journal-title":"N Engl J Med"},{"issue":"15","key":"616_CR18","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1200\/JCO.2009.22.4857","volume":"28","author":"J Zsiros","year":"2010","unstructured":"Zsiros J, Maibach R, Shafford E et al (2010) Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study. J Clin Oncol 28(15):2584\u20132590. doi: 10.1200\/JCO.2009.22.4857","journal-title":"J Clin Oncol"},{"issue":"9","key":"616_CR19","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S1470-2045(13)70272-9","volume":"14","author":"J Zsiros","year":"2013","unstructured":"Zsiros J, Brugieres L, Brock P et al (2013) Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study. Lancet Oncol 14(9):834\u2013842. doi: 10.1016\/S1470-2045(13)70272-9","journal-title":"Lancet Oncol"},{"issue":"6","key":"616_CR20","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1053\/jpsu.2002.32886","volume":"37","author":"F Sasaki","year":"2002","unstructured":"Sasaki F, Matsunaga T, Iwafuchi M et al (2002) Outcome of hepatoblastoma treated with the JPLT-1 (Japanese Study Group for Pediatric Liver Tumor) Protocol-1: a report from the Japanese Study Group for Pediatric Liver Tumor. J Pediatr Surg 37(6):851\u2013856","journal-title":"J Pediatr Surg"},{"issue":"1","key":"616_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00383-010-2708-0","volume":"27","author":"T Hishiki","year":"2011","unstructured":"Hishiki T, Matsunaga T, Sasaki F et al (2011) Outcome of hepatoblastomas treated using the Japanese Study Group for Pediatric Liver Tumor (JPLT) protocol-2: report from the JPLT. Pediatr Surg Int 27(1):1\u20138. doi: 10.1007\/s00383-010-2708-0","journal-title":"Pediatr Surg Int"},{"issue":"1","key":"616_CR22","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/pbc.10376","volume":"42","author":"JB Otte","year":"2004","unstructured":"Otte JB, Pritchard J, Aronson DC et al (2004) Liver transplantation for hepatoblastoma: results from the International Society of Pediatric Oncology (SIOP) study SIOPEL-1 and review of the world experience. Pediatr Blood Cancer 42(1):74\u201383. doi: 10.1002\/pbc.10376","journal-title":"Pediatric Blood Cancer"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-013-0616-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10147-013-0616-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-013-0616-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,24]],"date-time":"2019-07-24T06:50:44Z","timestamp":1563951044000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10147-013-0616-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,20]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["616"],"URL":"https:\/\/doi.org\/10.1007\/s10147-013-0616-8","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,20]]}}}